Back
Immunic 10K Form
Sell
40
IMUX
Immunic
Last Price:
1.25
Seasonality Move:
15.18%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive IMUX News And Ratings
See the #1 stock for the next 7 days that we like better than IMUX
IMUX Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $-24M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.93 |
| Price / Book: | 1.34 |
Profitability
| EPS (TTM): | -1.83000 |
|---|---|
| Net Income (TTM): | $-97.92M |
| Gross Margin: | $0 |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Immunic Earnings Forecast
Key Immunic Financial Ratios
- The Interest Expense is -6.12% of Operating Income.
- Per Share Earnings over the last 13 years have been positive in 8 years.
Immunic Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | IMUX |
| CUSIP: | 4525EP |
| Website: | imux.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |